DLG2 (PSD-93 or chapsyn-110) Antibody - FFPE Validated

Biological Background

To connect mechanism with measurement, this antibody lets you assess DLG2 in pathway-driven studies. DLG2 is a regulator within kinase-driven cascades that influence transcriptional and metabolic responses. Many projects interpret this target alongside interacting partners, upstream cues, and downstream readouts.

In some datasets and protocols, it is referenced by the gene symbol PSD-93.

Use in the Laboratory

Perturbations such as inhibitors or ligand stimulation can drive rapid shifts in localization or complex formation. Considering complex membership and compartment shifts can clarify whether changes reflect signaling or redistribution.

Interpreting changes can benefit from separating expression differences from redistribution, particularly when the target cycles between compartments.

To keep datasets interpretable, labs often document:

• localization shifts between cytoplasm, membrane, and nucleus
• time-resolved changes following stimulation or inhibition
• interaction patterns within multi-protein complexes

Version Notes

This fixed-section oriented version is intended for paraffin-embedded tissue, where crosslinking and retrieval steps can shape epitope accessibility. If your study compares multiple conditions, keep acquisition and processing settings stable to avoid confounding.

For challenging targets, pairing DLG2 measurements with a second marker can clarify whether differences arise from regulation, redistribution, or shifts in cell composition within the sample.

When interpreting DLG2, consider whether changes track with compartment identity, cell density, or perturbation timing; these factors can influence apparent signal without implying a direct causal link.

The fixed-section option supports mechanistic reading of DLG2 when interactions and context are the focus.